ID: ALA3277613

Max Phase: Preclinical

Molecular Formula: C16H39ClN4S2

Molecular Weight: 350.64

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCCCCCCNCCSSCCNCCCCCCN

Standard InChI:  InChI=1S/C16H38N4S2.ClH/c17-9-5-1-3-7-11-19-13-15-21-22-16-14-20-12-8-4-2-6-10-18;/h19-20H,1-18H2;1H

Standard InChI Key:  GPYNOGCPMUJTBM-UHFFFAOYSA-N

Associated Targets(non-human)

Adrenergic receptor alpha 950 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 350.64Molecular Weight (Monoisotopic): 350.2538AlogP: 2.59#Rotatable Bonds: 19
Polar Surface Area: 76.10Molecular Species: BASEHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 6#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.67CX LogP: 1.45CX LogD: -8.56
Aromatic Rings: 0Heavy Atoms: 22QED Weighted: 0.21Np Likeness Score: 0.14

References

1. Melchiorre C, Yong MS, Benfey BG, Belleau B..  (1978)  Molecular properties of the adrenergic alpha receptor. 2. Optimum covalent inhibition by two different prototypes of polyamine disulfides.,  21  (11): [PMID:31477] [10.1021/jm00209a007]

Source